ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0785

It Takes a Community: Exploring the Importance of Community-Level Social Determinants of Health in Total Knee Arthroplasty Outcomes

Chloe Heiting1, Yiyuan Wu2, Susan Goodman3, Peter Sculco4, Fei Wang2, Rich Caruana5, Peter Cram6, Said Ibrahim7 and Bella Mehta8, 1Northwell Health, New Hyde Park, NY, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4Hospital for Special Surgery, New York, NY, 5Microsoft, Redmond, WA, 6University of Maryland School of Medicine, Baltimore, MD, 7Thomas Jefferson University, Philadelphia, PA, 8Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ

Meeting: ACR Convergence 2025

Keywords: Arthroplasty, Disparities, Orthopedics, Outcome measures, race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation (0783–0788)

Session Type: Abstract Session

Session Time: 1:30PM-1:45PM

Background/Purpose: Despite changing trends and increased utilization of total knee arthroplasty (TKA) in the United States,1 there are still prominent racial and ethnic disparities in utilization and outcomes. This highlights the importance of exploring the social determinants of health (SDOH) that may play a role in disparities in TKA outcomes, especially as postoperative complications are of paramount concern in patient and provider consideration of TKA. We aimed to utilize prediction modeling to elucidate the relationship between adverse total knee arthroplasty outcomes – including 90-day readmission, 90-day mortality, 1-year revision, and length of stay (LOS) – and multiple community-level SDOH.

Methods: Patients who underwent TKA between 2012-2018 were identified from the Pennsylvania Health Care Cost Containment Council Database by ICD codes. Census-tract level community factors were extracted from the US census via geocoding. These SDOH variables included internet access, percent of unpaid family worker, with computer access, percent with no computer access, percent of having high school and above education, percent of having college and above education, national walking index, median income, living alone, total foreign born and percent of speak other language than English. This retrospective cohort study used explainable boosting machine (EBM), a modern form of generalized additive model (GAM), to predict 90-day readmission, 90-day mortality, and 1-year revision, and LOS. Area under the receiver operating curve (AUROC) and root mean squared error (RMSE) were used as evaluation metrics. Models were trained and tested using random train and test split and cross validation techniques to reduce overfitting and ensure robustness.

Results: We identified 215,414 patients undergoing TKA between 2012-2018 (Table 1). Model predictive performance was highest for mortality (AUROC=0.74), and was moderate for readmission (AUROC=0.64), revision (AUROC=0.62), and LOS (RMSE=0.35, R2=0.2) (Figure 1). Community factors were among the top five predictors of mortality, revision, and LOS.For readmission, the top 3 predictors were discharge location, comorbidities, and age (mean absolute scores = 0.16, 0.14, 0.10, respectively). For mortality, they were discharge location, community factors, and age (mean absolute scores = 0.31, 0.21, 0.21, respectively). The top 3 predictors of revision were comorbidities, community factors, gender (mean absolute scores = 0.18, 0.16, 0.09, respectively). Lastly, the top predictors for LOS were comorbidities, community factors, and age (mean absolute scores = 0.12, 0.05, 0.02, respectively).

Conclusion: In the prediction of 90-day readmission, 90-day mortality, 1-year revision, and LOS after TKA, community factors were more important than race in each of our examined models. This study provides additional nuance to the racial disparities within TKA outcomes and may suggest that community-level factors should also be considered and addressed to improve adverse TKA outcomes. Ravi B et al. The changing demographics of total joint arthroplasty recipients in the United States and Ontario from 2001 to 2007. PMID:23218428

Supporting image 1Table 1. Patient-level characteristics by outcome

Supporting image 2Figure 1. Variable importance plots in the prediction of total knee arthroplasty outcomes*


Disclosures: C. Heiting: None; Y. Wu: None; S. Goodman: Johnson and Johnson, 2, Novartis, 5, Pfizer, 2; P. Sculco: BetterPT, 8, Enovis, 2, 9, HS2, LLC, 8, HSS ASC Development Network, LLC, 8, Intellijoint Surgical, Inc, 8, Joint Effort Administrative Services Organization, 8, Osgenic, 1, 8, Parvizi Surgical Innovation, LLC, 8, Zimmer Biomet, 2, 5, 9; F. Wang: None; R. Caruana: None; P. Cram: None; S. Ibrahim: None; B. Mehta: Amgen, 1, Horizon, 1.

To cite this abstract in AMA style:

Heiting C, Wu Y, Goodman S, Sculco P, Wang F, Caruana R, Cram P, Ibrahim S, Mehta B. It Takes a Community: Exploring the Importance of Community-Level Social Determinants of Health in Total Knee Arthroplasty Outcomes [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/it-takes-a-community-exploring-the-importance-of-community-level-social-determinants-of-health-in-total-knee-arthroplasty-outcomes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/it-takes-a-community-exploring-the-importance-of-community-level-social-determinants-of-health-in-total-knee-arthroplasty-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology